ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 12 October to 18 October 2026

The 10 most important of the 57 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Sleep medicine · Sleep Med Rev · 2026-10-14

Meta-analysis of 53 studies (1,402,868 young people, 58 countries): 76.5% of children and 54.8% of adolescents met sleep duration recommendations; the adolescent difference was not significant after multiplicity adjustment. Prevalence was lower on school days.

Meta-analysisn = 1,402,868
Ezzatvar et al. Prevalence of meeting sleep duration recommendations among over 1.4 million children and adolescents across 58 countries: a systematic review and meta-analysis
Geriatrics · Lancet Healthy Longev · 2026-10-13

In an individual participant data meta-analysis of 13,851 adults, worsening hearing loss was associated with higher all-cause mortality (HR 1·19–1·56) and hearing-aid use with lower mortality (HR 0·91); replicated in 50,277 Norwegian adults.

Meta-analysisn = 13,851
Li et al. Hearing loss, hearing-aid use, and mortality risk: individual participant data meta-analysis of population-based studies from Australia, Iceland, and the USA and a replication study from Norway
Infectious diseases · Vaccine · 2026-10-13

In 4000 Thai adults after a two-dose COVID-19 primary series, a single HXP-GPOVac booster met non-inferiority to VAXZEVRIA for day-14 neutralising antibodies (GMC ratio 0.83; seroconversion difference −2.35%); solicited AEs 43.7% vs 53.5%.

RCTn = 4,000
Prasert et al. Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.